Why People with HIV Face Higher Rates of Lung Cancer

Lung cancer remains one of the most common and deadly forms of cancer worldwide. While smoking has long been recognized as the primary cause, new research reveals another significant risk group—people living with HIV (PLWH). Studies show that individuals with HIV are up to two to three times more likely to develop lung cancer compared to those without HIV, even after adjusting for smoking habits.

This blog explores the complex relationship between HIV and lung cancer, why this risk is elevated, and how people with HIV can reduce their chances through early detection, treatment, and lifestyle changes.

Understanding the Link Between HIV and Lung Cancer

1. The Role of the Immune System

The human immunodeficiency virus (HIV) attacks the immune system, specifically CD4 T-cells, which play a vital role in defending the body against infections and abnormal cell growth. When these cells are depleted, the immune system becomes less effective at detecting and destroying cancerous cells.

In healthy individuals, the immune system can often identify and eliminate abnormal cells before they develop into tumors. However, in people with HIV, this immune surveillance is weakened, allowing cancer cells—like those in the lungs—to multiply unchecked.

2. Chronic Inflammation and Cellular Damage

HIV causes chronic immune activation and inflammation, even when viral load is controlled through antiretroviral therapy (ART). This persistent inflammation leads to oxidative stress and DNA damage in the lungs, creating an environment conducive to cancer development.

Inflammation also accelerates the aging process of lung tissue, increasing the likelihood of mutations that can trigger tumor formation.

3. Smoking and Environmental Factors

Smoking remains the leading cause of lung cancer among all populations, but rates of smoking are significantly higher among people living with HIV. Studies suggest that up to 40–60% of HIV-positive individuals smoke cigarettes—double the rate seen in the general population.

Reasons for higher smoking prevalence in HIV-positive individuals include:

• Stress related to chronic illness
• Social and economic factors
• Coexisting mental health conditions such as depression or anxiety

Combined with immune suppression and inflammation, smoking drastically amplifies the risk of lung cancer in people with HIV.

4. Co-Infections and Opportunistic Pathogens

People with HIV are more prone to respiratory infections caused by bacteria, viruses, and fungi. Repeated lung infections—such as pneumonia, tuberculosis (TB), or cytomegalovirus—can damage lung tissue over time.

This scarring and inflammation may set the stage for malignant changes in the lung cells. Moreover, some co-infections can indirectly promote cancer by activating inflammatory pathways and suppressing the immune system further.

5. Effects of Antiretroviral Therapy (ART)

While ART has dramatically improved life expectancy for people with HIV, it has also changed the disease landscape. With longer lifespans, HIV-positive individuals are now more likely to develop non-AIDS-defining cancers such as lung cancer, liver cancer, and Hodgkin’s lymphoma.

• Some ART drugs may contribute indirectly to cancer risk by causing:
• Oxidative stress in lung tissue
• Metabolic changes that affect cellular repair mechanisms

However, it’s important to note that ART remains essential and reduces overall cancer risk by restoring immune function. The benefits of treatment far outweigh any potential side effects.

Epidemiology: How Common Is Lung Cancer Among People with HIV?

According to studies published by the U.S. National Cancer Institute and the World Health Organization (WHO):

• Lung cancer is the most common non-AIDS-related cancer among people with HIV.
• HIV-positive individuals are twice as likely to develop lung cancer as those without HIV.
• The average age of diagnosis in HIV-positive patients is younger (around 45–55 years) compared to HIV-negative populations (60–70 years).
• Lung cancer tends to be diagnosed at a later stage in HIV-positive individuals, which contributes to poorer outcomes.

Symptoms of Lung Cancer in People with HIV

Early detection is challenging because symptoms of lung cancer often overlap with common respiratory infections in HIV-positive individuals. However, awareness of the signs can lead to earlier diagnosis and better outcomes.

Common symptoms include:

Persistent cough or changes in cough pattern

• Shortness of breath
• Chest pain or discomfort
• Coughing up blood (hemoptysis)
• Unexplained weight loss
• Fatigue or loss of appetite

If any of these symptoms persist for more than two weeks, individuals should consult a healthcare provider promptly for evaluation.

Diagnosis and Screening

1. Imaging Tests

The most common tools for detecting lung cancer include:

• Chest X-rays
• CT scans (computed tomography)

Low-dose CT screening is increasingly recommended for high-risk populations, including older adults with HIV who smoke or have a history of heavy smoking.

2. Biopsy and Laboratory Tests

When imaging reveals suspicious areas, a biopsy is necessary to confirm lung cancer. Pathologists examine tissue samples to determine the type and stage of cancer.

3. Regular Monitoring

For people with HIV, regular monitoring of CD4 count and viral load is crucial. Stable immune function reduces overall cancer risk and improves recovery if cancer is detected early.

Treatment Options for Lung Cancer in HIV-Positive Patients

Treating lung cancer in people with HIV requires a multidisciplinary approach. Most patients can safely undergo standard cancer treatments, provided their HIV is well controlled.

1. Surgery

Surgical removal of tumors may be an option for early-stage lung cancer. However, careful evaluation is necessary to assess immune health and the ability to recover from surgery.

2. Radiation Therapy

Radiation can target specific lung areas to destroy cancer cells. It is commonly used alongside chemotherapy or when surgery isn’t possible.

3. Chemotherapy

Chemotherapy remains effective, but it can interact with ART drugs. Physicians often adjust dosages or choose alternative regimens to prevent adverse interactions.

4. Immunotherapy

Emerging research suggests that immune checkpoint inhibitors—drugs that activate the immune system to attack cancer cells—may benefit some HIV-positive patients. However, more clinical trials are needed to confirm safety and efficacy.

Prevention: Reducing Lung Cancer Risk in People with HIV

1. Quit Smoking

The single most effective way to lower lung cancer risk is to stop smoking. Support groups, nicotine replacement therapies, and medications such as bupropion or varenicline can help.

2. Maintain Consistent ART

Adherence to ART helps maintain strong immune function, reducing the body’s susceptibility to cancer-causing mutations.

3. Regular Screening

People with HIV—especially those over 40 or with a smoking history—should discuss annual low-dose CT scans with their doctor.

4. Manage Co-Infections

Promptly treating respiratory infections and preventing TB can reduce chronic inflammation in the lungs.

5. Adopt a Healthy Lifestyle

A balanced diet, regular exercise, and adequate sleep strengthen the immune system and support overall health.

Future Research and Hope

Medical research continues to explore the biological mechanisms linking HIV and lung cancer. Current studies are examining:

• How chronic inflammation accelerates tumor growth
• The potential protective role of specific ART drugs
• The effectiveness of immunotherapy in HIV-positive cancer patients

With continued research and access to quality healthcare, survival rates for people with both HIV and lung cancer are gradually improving.

Conclusion

The elevated rates of lung cancer among people with HIV stem from a combination of factors immune suppression, chronic inflammation, smoking, and prolonged life expectancy due to ART. While the risk is real, it is not inevitable.

By quitting smoking, maintaining antiretroviral therapy, undergoing regular screening, and leading a healthy lifestyle, people living with HIV can significantly reduce their risk and live longer, healthier lives.